Tag
Daiichi Sankyo
- Summit Therapeutics plans Phase III Datroway breast cancer trial
- Merck and Daiichi Sankyo withdraw ifinatamab deruxtecan BLA
- Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI
- This year's World Conference on Lung Cancer is coming to Barcelona
- GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most